SMHS Researcher of the Year awarded to leading bladder cancer researcher
Fiona Stanley Fremantle Hospitals Group (FSFHG) Head of Urology Professor Dickon Hayne was recently named SMHS Researcher of the Year for his commitment to improving treatments and outcomes for bladder cancer, a difficult-to-treat condition with decreasing survival outcomes.
Among his recent contributions, Dickon is leading the world’s largest trial which is currently recruiting to investigate high risk, non-muscle invasive bladder cancer. His work could change how the disease is managed globally.
His other recent research includes developing trials in the emerging field of theranostics – a novel way of combining diagnostic imaging techniques with delivering therapy agents.
Last Thursday, 20 October 2022, Dickon was recognised for his contribution to patient outcomes, taking home the top prize in the category ‘Researcher of the Year’ at the 2022 South Metropolitan Health Service (SMHS) Excellence Awards.
Dickon said he is very proud to have been recognised as researcher of the year but emphasised none of this would have been possible without the teams behind the research as well.
“Research is genuinely a team sport, with hundreds of people involved in all facets of the various trials – so thank you to each one of those people involved in the research which helped us get here,” Dickon said.
“Research is only expanding at SMHS and I am very proud to be part of a health provider which values research so highly.
“But it is never over – one study often takes several years and there is always more to learn – research really is a long game, so it’s nice to be recognised for my work though it never quite feels ‘finished’.
“I am very excited, flattered and humbled by this win – thank you.”
SMHS Chief Executive Paul Forden said he is continually impressed by the high calibre projects, teams and individuals who are in the running at the SMHS Excellence Awards every year.
“We are privileged at SMHS to have a cohort of staff and volunteers who are so passionate and committed to further improving the patient outcomes for our community,” Paul said.
Read more about our finalists and winners.